Personalising ART with Science –
Shifting the paradigm in ovarian stimulation

We are delighted to invite you to attend the Ferring-sponsored FSA 2018 breakfast symposium: “Personalising ART with Science – shifting the paradigm in ovarian stimulation”. Professor Juan García-Velasco, Director of IVI Madrid and Professor of Obstetrics and Gynaecology at Rey Juan Carlos University, Madrid will present data as a lead investigator from the pivotal phase III trial (ESTHER1) from the development programme for Ferring’s new recombinant human follicle stimulating hormone, follitropin delta (REKOVELLE®) and its associated dosing algorithm. He will also share experience in managing the transition to using REKOVELLE® in real-world clinical practice within IVI. This theme will be explored further from an Australian perspective, with a local clinician discussing their experience with using the REKOVELLE® dosing algorithm and how this impacts on current clinical practice. This promises to be an engaging meeting where the latest developments in personalising ovarian stimulation will be discussed, whilst the panel discussion will give you the opportunity to pose your questions to the faculty.

Date: MONDAY 10 September 2018
Time: 0700 – 0815
Venue: Eureka Rooms 1&2

Registration for the breakfast can be made through the conference delegate registration form.